HICON

HICON was a specialized contract manufacturing organization (CMO) based in the Netherlands, focused on the production of biopharmaceuticals using microbial fermentation. The company provided a range of services including process development, scale-up, and cGMP manufacturing of recombinant proteins and vaccines for clinical and commercial use. HICON was particularly noted for its expertise in high-cell-density fermentation and downstream processing. In 2000, the company was acquired by SynCo Bio Partners, which integrated HICON's capabilities into its broader biopharmaceutical manufacturing service offering. The facility in Amsterdam continued to serve as a key site for microbial-based production under the SynCo brand.